AIM ImmunoTech Inc. (AIM) stock
AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.14+0.01 (+3.82%)
Close on Nov 17, 2026Market cap $4.14MP/E –Yield –
AIM ImmunoTech market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
AIM ImmunoTech's market cap was $4.30M on Nov 11, 2026, against $4.20M a year earlier. Over the last 5 years it ranged from $1.59M to $50.82M, with a median of $18.71M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.30M | +37.9% |
| 2025 | Dec 31, 2025 | $3.12M | -73.1% |
| 2024 | Dec 31, 2024 | $11.60M | -45.9% |
| 2023 | Dec 29, 2023 | $21.44M | +43.9% |
| 2022 | Dec 30, 2022 | $14.91M | -66.1% |
| 2021 | Dec 31, 2021 | $43.98M | -39.6% |
| 2020 | Dec 31, 2020 | $72.75M | +2109.7% |
| 2019 | Dec 31, 2019 | $3.29M | -62.0% |
| 2018 | Dec 31, 2018 | $8.67M | -20.3% |
| 2017 | Dec 29, 2017 | $10.88M | -34.5% |
| 2016 | Dec 30, 2016 | $16.61M | -16.1% |
| 2015 | Dec 31, 2015 | $19.81M | -59.1% |
| 2014 | Dec 31, 2014 | $48.43M | +7.1% |
| 2013 | Dec 31, 2013 | $45.23M | +22.6% |
| 2012 | Dec 31, 2012 | $36.88M | +36.1% |
| 2011 | Dec 30, 2011 | $27.11M | – |
See a number that looks wrong?